ALSE — Alseres Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Alseres Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.315 | 0.099 | 0.163 | 0.897 | 0.321 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.388 | 0.209 | 0.168 | 0.9 | 0.325 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.106 | 0.048 | 0.002 | 0.001 | 0 |
| Other Long Term Assets | |||||
| Total Assets | 0.791 | 0.461 | 0.171 | 0.966 | 0.385 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.92 | 37.6 | 30.4 | 10.1 | 1.65 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 43.2 | 42.3 | 30.4 | 27.3 | 10.7 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -42.4 | -41.9 | -30.3 | -26.4 | -10.3 |
| Total Liabilities & Shareholders' Equity | 0.791 | 0.461 | 0.171 | 0.966 | 0.385 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |